Breast Cancer Liquid Biopsy Testing Devices Market Size to Grow by USD 730.4 Mn, CTCs and Circulating Nucleic Acids to be Largest Revenue-generating Type Segment - Technavio

News provided by

Nov 08, 2022, 13:40 ET

NEW YORK, Nov. 8, 2022 /PRNewswire/ -- The breast cancer liquid biopsy testing devices market share growth by the CTCs and circulating nucleic acids segment will be significant during the forecast period. Healthcare professionals use CTCs and circulating nucleic acids for different types of cancer, including breast, prostate, lung, and colorectal cancers. The growth of this segment is driven by factors such as increasing chances of an accurate snapshot of the genomic landscape, easy identification of cancer, and the increasing need to identify mutations causing metastases.

Technavio has announced its latest market research report titled Global Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026

The breast cancer liquid biopsy testing devices market size is expected to grow by USD 730.4 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 23.58% during the forecast period, according to Technavio. The report offers an up-to-date analysis of the market, and to know the exact growth variance and the Y-O-Y growth rate, Request a FREE Sample Report.

Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026: Scope

The report on the breast cancer liquid biopsy testing devices market covers the following areas:

This study identifies technological advances as one of the prime reasons driving the breast cancer liquid biopsy testing devices market growth during the next few years. However, factors such as the high costs that are associated with liquid biopsy testing may challenge the market growth.

Subscribe to our "Basic Plan" billed annually at USD 5000 that enables you to download 5 reports and view 100 reports per month

Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026: Segmentation

Type

CTCs and Circulating Nucleic Acids
Extracellular Vesicles

Geography

North America
Europe
Asia
Rest Of World (ROW)

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the breast cancer liquid biopsy testing devices market, including Agena Bioscience Inc., A. Menarini Industrie Farmaceutiche Riunite Srl, Exact Sciences Corp., Bio Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann La Roche Ltd., Illumina Inc., Guardant Health Inc., Myriad Genetics Inc., Isogen Life Science BV, NeoGenomics Laboratories Inc., Natera Inc., OncoDNA SA, Novogene Corp., QIAGEN NV, Pfizer Inc., Sysmex Corp., SAGA Diagnostics AB, and Thermo Fisher Scientific Inc., among others, are some of the major market participants.

This report provides a full list of key vendors, their strategies, and latest developments. Buy Now for detailed vendor information

Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026: Key Highlights

CAGR of the market during 2022-2026
Detailed information on factors that will help the breast cancer liquid biopsy testing devices market grow during the next five years
Approximation of the breast cancer liquid biopsy testing devices market size and its contribution to the parent market
Forecasts on upcoming trends and changes in consumer behavior
The growth of the global breast cancer liquid biopsy testing devices market
Analysis of the competitive landscape and detailed information on vendors
Comprehensive details of factors that will impede the growth of the breast cancer liquid biopsy testing devices market vendors

Related Reports

Breast Imaging Technologies Market by Type and Geography - Forecast and Analysis 2022-2026: The growing focus on courses and medical exhibitions for breast imaging products is a trend in the market. For instance, WORLD CLASS CME released a course on Breast Ultrasound with Tom Stavros in 2019. The objective of this course is to make the target audience understand the anatomic and histopathologic basis for ultrasound appearances, among others.

Breast Tissue Expander Market by Product and Geography - Forecast and Analysis 2022-2026: Technological advances are a trend in the market. The emergence of NGS in liquid biopsy procedures for breast tumors has led to a significant reduction in the cost of the procedures and improved their accuracy. For instance, in December 2020, Biocept, Inc. announced results from a prospective study that showed Target Selector was highly accurate in monitoring HER2 alterations in patients with metastatic breast cancer.

Breast Cancer Liquid Biopsy Testing Devices Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 23.58%
Market growth 2022-2026	USD 730.4 million
Market structure	Fragmented
YoY growth (%)	23.13
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 42%
Key consumer countries	US, Canada, Germany, France, UK, and China
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	A. Menarini Industrie Farmaceutiche Riunite Srl, Agena Bioscience Inc., Bio Rad Laboratories Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Novogene Corp., OncoDNA SA, Pfizer Inc., QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp., and Thermo Fisher Scientific Inc.
Market Dynamics	Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table Of Contents

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers

Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments

Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

5.2 Comparison by Type

Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type

5.3 CTCs and circulating nucleic acids - Market size and forecast 2021-2026

Exhibit 28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)

5.4 Extracellular vesicles - Market size and forecast 2021-2026

Exhibit 32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Type

Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview

Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation

Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison

Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026

Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026

Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026

Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026

Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026

Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 Canada - Market size and forecast 2021-2026

Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.10 China - Market size and forecast 2021-2026

Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

7.11 France - Market size and forecast 2021-2026

Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)

7.12 UK - Market size and forecast 2021-2026

Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.13 Market opportunity by geography

Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

Exhibit 83: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption

Exhibit 85: Overview on factors of disruption

9.4 Industry risks

Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered

Exhibit 87: Vendors covered

10.2 Market positioning of vendors

Exhibit 88: Matrix on vendor position and classification

10.3 A. Menarini Industrie Farmaceutiche Riunite Srl

Exhibit 89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibit 90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibit 91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings

10.4 Exact Sciences Corp.

Exhibit 92: Exact Sciences Corp. - Overview
Exhibit 93: Exact Sciences Corp. - Product / Service
Exhibit 94: Exact Sciences Corp. - Key offerings

10.5 F. Hoffmann La Roche Ltd.

Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus

10.6 Illumina Inc.

Exhibit 100: Illumina Inc. - Overview
Exhibit 101: Illumina Inc. - Business segments
Exhibit 102: Illumina Inc. - Key news
Exhibit 103: Illumina Inc. - Key offerings
Exhibit 104: Illumina Inc. - Segment focus

10.7 Isogen Life Science BV

Exhibit 105: Isogen Life Science BV - Overview
Exhibit 106: Isogen Life Science BV - Product / Service
Exhibit 107: Isogen Life Science BV - Key offerings

10.8 Myriad Genetics Inc.

Exhibit 108: Myriad Genetics Inc. - Overview
Exhibit 109: Myriad Genetics Inc. - Product / Service
Exhibit 110: Myriad Genetics Inc. - Key offerings

10.9 Natera Inc.

Exhibit 111: Natera Inc. - Overview
Exhibit 112: Natera Inc. - Product / Service
Exhibit 113: Natera Inc. - Key offerings

10.10 Novogene Corp.

Exhibit 114: Novogene Corp. - Overview
Exhibit 115: Novogene Corp. - Product / Service
Exhibit 116: Novogene Corp. - Key offerings

10.11 QIAGEN NV

Exhibit 117: QIAGEN NV - Overview
Exhibit 118: QIAGEN NV - Product / Service
Exhibit 119: QIAGEN NV - Key news
Exhibit 120: QIAGEN NV - Key offerings

10.12 Thermo Fisher Scientific Inc.

Exhibit 121: Thermo Fisher Scientific Inc. - Overview
Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
Exhibit 123: Thermo Fisher Scientific Inc. - Key news
Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist

11.3 Currency conversion rates for US$

Exhibit 128: Currency conversion rates for US$

11.4 Research methodology

Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources

11.5 List of abbreviations

Exhibit 132: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio